Itron, Inc. (NASDAQ:ITRI) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Key Points

• Analysts rate Itron a "Moderate Buy" — 13 firms cover the stock (eight buys, five holds) with an average 1‑year target price of $137.10.
• Quarterly beat and raised guidance: Itron reported $2.46 EPS vs $2.19 expected and $571.7M revenue, and set Q1 2026 guidance of 1.20–1.30 EPS and FY2026 guidance of 5.75–6.25 EPS.
• Insider selling notable: Executives (including the SVP and CFO) sold a combined 51,180 shares (~$5.09M) in the last 90 days, leaving insiders with 1.77% ownership.

Shares of Itron, Inc. (NASDAQ:ITRI - Get Free Report) have been given an average recommendation of "Moderate Buy" by the thirteen ratings firms that are covering the company, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $137.10.

Several research analysts have commented on ITRI shares. Robert W. Baird set a $128.00 price target on shares of Itron and gave the stock an "outperform" rating in a report on Wednesday, February 18th. Guggenheim set a $155.00 price target on shares of Itron in a report on Friday, February 13th. Wall Street Zen cut shares of Itron from a "buy" rating to a "hold" rating in a report on Wednesday, January 14th. Weiss Ratings cut shares of Itron from a "buy (b-)" rating to a "hold (c+)" rating in a report on Monday, January 12th. Finally, Oppenheimer upped their target price on shares of Itron from $125.00 to $133.00 and gave the company an "outperform" rating in a report on Wednesday, February 18th.

Insiders Place Their Bets

In other news, SVP Donald L. Reeves III sold 5,419 shares of the company's stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $99.54, for a total value of $539,407.26. Following the completion of the transaction, the senior vice president owned 33,140 shares in the company, valued at approximately $3,298,755.60. This represents a 14.05% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Joan S. Hooper sold 15,293 shares of the company's stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $99.54, for a total transaction of $1,522,265.22. Following the completion of the transaction, the chief financial officer owned 124,196 shares of the company's stock, valued at approximately $12,362,469.84. The trade was a 10.96% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 51,180 shares of company stock worth $5,085,475. 1.77% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Employees Retirement System of Texas acquired a new position in shares of Itron in the 3rd quarter valued at $32,000. Private Trust Co. NA boosted its holdings in shares of Itron by 112.4% in the 4th quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company's stock valued at $25,000 after buying an additional 145 shares in the last quarter. Optiver Holding B.V. purchased a new stake in Itron in the 3rd quarter valued at $36,000. Salomon & Ludwin LLC purchased a new stake in Itron in the 3rd quarter valued at $42,000. Finally, Northwestern Mutual Wealth Management Co. raised its position in Itron by 343.6% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company's stock valued at $46,000 after purchasing an additional 268 shares during the last quarter. Institutional investors and hedge funds own 96.19% of the company's stock.

Itron Trading Up 2.0%

NASDAQ ITRI opened at $96.36 on Wednesday. The company has a quick ratio of 1.56, a current ratio of 1.80 and a debt-to-equity ratio of 0.45. Itron has a 52 week low of $83.51 and a 52 week high of $142.00. The stock has a market capitalization of $4.27 billion, a PE ratio of 14.80, a price-to-earnings-growth ratio of 0.82 and a beta of 1.50. The firm has a 50 day moving average of $93.98 and a two-hundred day moving average of $101.95.

Itron (NASDAQ:ITRI - Get Free Report) last posted its quarterly earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 EPS for the quarter, topping the consensus estimate of $2.19 by $0.27. Itron had a net margin of 12.72% and a return on equity of 20.04%. The company had revenue of $571.66 million during the quarter, compared to analysts' expectations of $561.31 million. During the same quarter in the previous year, the business posted $1.35 EPS. The firm's revenue was down 6.7% on a year-over-year basis. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. As a group, research analysts expect that Itron will post 5.33 EPS for the current fiscal year.

About Itron

Itron, Inc NASDAQ: ITRI is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company's offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron's product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.